You are here

  • Home
  • Archive
  • Volume 98, Issue 4
  • High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype

https://doi.org/10.1136/heartjnl-2011-301129

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding This study was partly supported by grants from the Institute of the Health Sciences, Gyeongsang National University and Sinai Hospital Baltimore.

    • Competing interests Dr Jeong received honoraria from Sanofi-Aventis, Daiichi Sankyo Inc. and Otsuka. Dr Gurbel received research grants, honoraria and consultant fees from Haemoscope, AstraZeneca, Schering-Plough/Merck, Medtronic, Lilly/Daiichi Sankyo Inc., Sanofi-Aventis/Bristol Myers, Portola, Boston Scientific, Bayer, Novartis, Accumetrics, Boehringer Ingelheim and Johnson & Johnson.

    • Patient consent Obtained.

    • Ethics approval Ethics approval was obtained from the Gyeongsang National University Hospital institutional review board.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles

    • PostScript
      The Authors' reply
      Nicoline J Breet Jochem W van Werkum Heleen J Bouman Johannes C Kelder Ankie M Harmsze Christian M Hackeng Jurriën M ten Berg
      Heart 2012; 98 343-344 Published Online First: 20 Jan 2012. doi: 10.1136/heartjnl-2011-301435